The MAGiC™ Cardiac Ablation European Study
← catalyst calendarNCT06019845 · readout in 499 d
Sponsored by Stereotaxis (industry) · STXS — their whole pipeline →. With Osypka AG.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
150estimated
Sites
4
Countries
Denmark, Lithuania, Netherlands +1
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-01-02 | actual | When the study began enrolling |
| Primary completion | 2027-12-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2023-08-31 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-04 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Arrhythmias, Cardiac
Intervention
- Device: MAGiC™
Primary outcomes
what the primary-completion date above is the date OFAcute Performance
measured hospital discharge - up to 7 days post procedure
Acute Safety
measured hospital discharge - up to 7 days post procedure
Permalink · STXS's whole pipeline · Catalyst calendar · Every registered study · What changed